Found 12 matching trials
VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
N/AThe investigators aimed to use pharmacogenetic information in clinical prac...
Location
Ankara University Medical Faculty, Department of Cardiovascular Surgery and Pulmonary Disease
Genotype-Guided Warfarin Therapy Trial
NAThe purpose of the investigators' study is to determine the clinical utilit...
Location
UNC Hospitals, UNC Anticoagulation Clinic at the Ambulatory Care Center (ACC), UNC Family Medicine Center Anti-coagulation Clinic
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
PHASE4The purpose of this study is to determine whether pharmacogenetic guided do...
Location
Institute of geriatric Cardiology, General Hospital of People's Liberation Army
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
PHASE4Background: Time in therapeutic range (TTR) is a measurement of quality of ...
Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
PHASE3Interethnic differences in warfarin dose requirements in the Asian populati...
Location
University of Malaya Medical Centre
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
NASeveral human genes affect how medications are metabolized by the body. It ...
Location
University of Utah Health Care
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
PHASE2The purpose of this study is to determine whether DNA analysis improves the...
Location
Intermountain Healthcare Hospitals and Clinics
Pharmacogenetics of Acenocoumarol
N/AThe use of oral anticoagulation is marked by an elevated risk of adverse dr...
Location
University Hospitals
Warfarin Anticoagulation in Patients in Sub-Saharan Africa
N/AThis research programme aims to translate expertise in warfarin anticoagula...
Location
University of Cape Town
A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
NAAnticoagulation with warfarin is a common and potentially hazardous therape...